Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedOct 22, 2014Propranolol HClcGMP Deviations: GYMA laboratories Inc. has recalled multiple Active Pharmaceutical Ingredients manufactured in Italy upon receipt of a Rapid Alert Notification issued...Gyma Laboratories Of Amer,Inc · D-0022-2015Class IITerminatedOct 22, 2014Dipyridamole APIcGMP Deviations: GYMA laboratories Inc. has recalled multiple Active Pharmaceutical Ingredients manufactured in Italy upon receipt of a Rapid Alert Notification issued...Gyma Laboratories Of Amer,Inc · D-0021-2015Class ITerminatedOct 22, 2014Lidocaine HCl InjectionPresence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.Hospira Inc. · D-0020-2015Class IIITerminatedOct 22, 2014VasotecLabeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.Valeant Pharmaceuticals North America LLC · D-0019-2015Class IIITerminatedOct 22, 2014VasereticLabeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outsetValeant Pharmaceuticals North America LLC · D-0018-2015Class IITerminatedOct 22, 2014Atorvastatin Calcium 40 MG TabletPresence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose packslabeled as Atorvastatin CalciumUnit Dose Solutions Inc · D-0017-2015Class IITerminatedOct 22, 2014HYDROXYPROGESTERONE CAPROATE 250 MG/MLCrystallization: Formation of crystals observed in product.Avella of Deer Valley, Inc. · D-0016-2014Class IITerminatedOct 22, 2014TOPIRAMATE Tablets 200 mgPresence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.Zydus Pharmaceuticals USA Inc · D-0015-2015Class IIITerminatedOct 15, 2014E-Z- GAS II EFFERVESCENT GRANULES Antacid/AntiflatulentSubpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.Bracco Diagnostic Inc · D-0014-2015Class IIITerminatedOct 15, 2014TruvadaPresence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.Gilead Sciences, Inc. · D-0013-2015Class IITerminatedOct 15, 2014All sterile products within expiryLack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be...Unique Pharmaceutical, Ltd · D-0012-2015Class ITerminatedOct 15, 2014N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense.Unique Pharmaceutical, Ltd · D-0011-2015Class IITerminatedOct 15, 2014METOCLOPRAMIDE ORAL SOLUTIONDefective Container: Product leaks when inverted.VistaPharm, Inc. · D-0010-2015Class IITerminatedOct 15, 2014Metoprolol Succinate Extended-release TabletsPresence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of MetoprololMylan Pharmaceuticals Inc. · D-0009-2015Class IITerminatedOct 15, 2014TarcevaFailed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.Astellas Pharma US Inc · D-0008-2015Class IITerminatedOct 15, 2014ZyGenerics ATENOLOL TabletsSuperpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.Zydus Pharmaceuticals USA Inc · D-0007-2015Class IITerminatedOct 15, 2014XareltoMicrobial Contamination of Non-Sterile Products: Consumer complaint confirmed microbial contamination in sales sample.Janssen Ortho L.L.C. · D-0006-2015Class IITerminatedOct 15, 2014Amiodarone HCl InjectionTemperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of...Mckesson · D-0005-2015Class ITerminatedOct 8, 2014AFRICAN BLACK ANTMarketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.Eugene Oregon, Inc. · D1612-2014Class IITerminatedOct 8, 2014Diclofenac Sodium and Misoprostol Delayed-Release TabletsFailed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.Actavis Laboratories, FL, Inc. · D-1617-2014Class IITerminatedOct 8, 2014Diclofenac Sodium and Misoprostol Delayed-Release TabletsFailed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.Actavis Laboratories, FL, Inc. · D-1616-2014Class IITerminatedOct 8, 2014Zoledronic Acid Injection 5 mg per 100 mLLack of Assurance of Sterility; leaking of premix bagsSagent Pharmaceuticals Inc · D-1615-2014Class ITerminatedOct 8, 2014MOJO RISENMarketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.Eugene Oregon, Inc. · D-1614-2014Class ITerminatedOct 8, 2014Black AntMarketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.Eugene Oregon, Inc. · D-1613-2014Class IITerminatedOct 8, 2014CREON (pancrelipase) Delayed-Release CapsulesPresence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.AbbVie Inc · D-1611-2014Class ITerminatedOct 8, 2014Dianeal Low CalciumPresence of Particulate Matter: particulate matter was found during the manufacturing process.Baxter Healthcare Corp. · D-1610-2014Class IITerminatedOct 8, 2014DOPamine Hydrochloride and 5% Dextrose INJLack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the...Baxter Healthcare Corp. · D-0004-2015Class IITerminatedOct 8, 2014All sterile drugs compounded between 2/21/14 and 2/24/14Lack of Assurance of Sterility: All compounded products.New England Home Therapies, Inc · D-0003-2015Class ITerminatedOct 8, 2014MarcainePresence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.Hospira Inc. · D-0002-2015Class ITerminatedOct 8, 2014CUBICINPresence of Particulate Matter: Potential presence of glass particulate matter in the vials.Cubist Pharmaceuticals, Inc. · D-0001-2015Class IIITerminatedOct 1, 2014Olanzapine Orally Disintegrating Tablets 5 mgSubpotent Drug: Out of specification (OOS) results at the 9 month temperature point.Apotex Corp. · D-1609-2014Class IITerminatedOct 1, 2014DaytranaDefective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver...Noven Pharmaceuticals, Inc. · D-1608-2014Class IITerminatedOct 1, 2014Oxycodone and Acetaminophen Tablets USP 10 mg/325 mgFailed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone...Alvogen, Inc · D-1607-2014Class IITerminatedOct 1, 2014Potassium Chloride InjectionCorrect Labeled Product Mispack: Shipping cartons labeled as containing Potassium Chloride injection actually contained bags labeled and containing Gentamicin Sulfate...Baxter Healthcare Corp · D-1606-2014Class IIITerminatedOct 1, 2014MethylPREDNISolone TABLETSSubpotent; 6 month stability time pointQualitest Pharmaceuticals · D-1605-2014Class IITerminatedOct 1, 2014Buprenorphine Hydrochloride InjectionFailed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point.Hospira Inc. · D-1604-2014Class IIITerminatedOct 1, 2014Rifampin for Injection USPFailed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time pointAkorn, Inc. · D-1571-2014Class ITerminatedSep 24, 2014MOJO RISENMarketed Without an Approved NDA/ANDA; Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined...Nova Products, Inc. · D-1603-2014Class ITerminatedSep 24, 2014XZONE GOLDMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZONE GOLD because FDA laboratory analysis determined that...Nova Products, Inc. · D-1602-2014Class ITerminatedSep 24, 2014Xzone 1200Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZone 1200because FDA laboratory analysis determined that they...Nova Products, Inc. · D-1601-2014